Vascular Dementia
📧 Sign up to get email alerts when something new happens for Vascular Dementia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-07-06Clinical Trial Update: Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
This clinical trial update reports the performance of AclarusDx, a blood-based transcriptomic test for Alzheimer's disease, in US patients n…
-
CLINICAL_TRIALS trial_result · 2012-05-04Clinical Trial Update: Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia [Phase 4]
Phase 4 trial evaluating the efficacy and safety of donepezil hydrochloride (Aricept) for vascular dementia has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-21Clinical Trial Update: Study of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency) [Phase 2]
Phase 2 trial of STA-1 Capsule in vascular dementia has completed. No results are reported in the update.
-
CLINICAL_TRIALS trial_result · 2011-11-17Clinical Trial Update: Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia [Phase 3]
This document reports a completed Phase 3 trial evaluating rivastigmine capsules for probable vascular dementia. It focuses on efficacy and …
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia [Phase 3]
This update reports the completion of a Phase 3 placebo-controlled trial evaluating galantamine for vascular dementia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia [Phase 3]
This Phase 3 trial evaluated the safety and effectiveness of galantamine versus placebo in patients with vascular dementia or mixed dementia…
-
CLINICAL_TRIALS trial_result · 2011-04-01Clinical Trial Update: Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease [Phase 3]
A Phase 3 study evaluating donepezil hydrochloride (E2020) for dementia associated with cerebrovascular disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-03-31Clinical Trial Update: Non-Interventional Study With Aricept® Evess
Pfizer conducted a completed non-interventional study of Aricept Evess (donepezil transdermal patch) for Alzheimer's disease and vascular de…
-
CLINICAL_TRIALS trial_result · 2011-01-14Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia [Phase 3]
A Phase 3 trial evaluated the effectiveness and safety of risperidone for behavioral disturbances in dementia patients and has completed.
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia [Phase 3]
Phase 3 randomized trial comparing risperidone to placebo for behavioral disturbances in dementia patients has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia [Phase 3]
This document reports results from a Phase 3 trial evaluating the effectiveness and safety of risperidone for behavioral disturbances in pat…
-
CLINICAL_TRIALS trial_result · 2009-09-21Clinical Trial Update: Cognitive and Emotional Impairment After Stroke [NA]
A completed clinical trial update examining cognitive and emotional impairment after stroke. The update references considerations related to…
-
CLINICAL_TRIALS trial_result · 2009-07-28Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia [Phase 4]
Phase 4 trial evaluating safety and efficacy of 20 ml Cerebrolysin in vascular dementia has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2009-06-12Clinical Trial Update: Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia [Phase 3]
Pfizer-sponsored Phase 3 open-label study of donepezil in vascular dementia and mixed dementia was terminated, with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Seroquel- Agitation Associated With Dementia [Phase 3]
Phase 3 trial of quetiapine (Seroquel) for agitation in Alzheimer's disease and vascular dementia has completed.
-
CLINICAL_TRIALS trial_result · 2009-01-12Clinical Trial Update: Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease [Phase 3]
Phase 3 trial update reporting safety findings for donepezil in patients with vascular dementia, with the study status indicating completion…
-
CLINICAL_TRIALS trial_result · 2008-10-01Clinical Trial Update: Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach? [NA]
A clinical trial evaluating systematic care for informal caregivers of dementia patients has completed.
-
CLINICAL_TRIALS trial_result · 2007-05-16Clinical Trial Update: Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia [Phase 3]
Phase 3 clinical trial update evaluating dopamine transporter imaging with ioflupane (DaTscan) in Lewy body dementia and other dementias has …
-
CLINICAL_TRIALS trial_result · 2006-08-29Clinical Trial Update: Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's Dementia [Phase 4]
Phase 4 trial comparing escitalopram to placebo for depressive symptoms in patients with Alzheimer's disease, vascular dementia, or mixed de…